Publications

Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.

Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.

See below for some of our recent publications.

Bardoxolone for Chronic Kidney Disease in Alport Syndrome

Bardoxolone is an investigational oral nuclear factor erythroid-derived 2-related factor 2 (Nrf2) activator proposed to slow the progression of kidney disease in patients aged ≥ 12 years with chronic kidney disease caused by Alport Syndrome.

Platelet-Rich Plasma for Wound Treatment in Diabetic Foot Ulcers

Focus of the Report: This health technology assessment focuses on the use of platelet-rich plasma (PRP) for treatment of diabetic foot ulcers (DFUs).

Technology Description: PRP is an autologous blood preparation with a higher-than-usual concentration of platelets, platelet-derived gro…

Enjaymo (Sutimlimab-jome) for Cold Agglutinin Disease

Enjaymo (sutimlimab-jome) is an intravenous monoclonal antibody classical complement inhibitor indicated to decrease the need for red blood cell (RBC) transfusion due to hemolysis in adults with cold agglutinin disease.